Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Spinocerebellar ataxia type 5 caused by spectrin SPTBN2 mutations

Nov. 4, 2005

New treatment options for neuropsychiatric disorders claimed in recent patent literature

Nov. 4, 2005

Melanocortin receptor agonist emerges from Astellas Pharma R&D

Nov. 4, 2005

Clinical data supports the use of extended-release methylphenidate in ADHD

Nov. 4, 2005

Maruho to develop and market DepoBupivacaine in Japan

Nov. 4, 2005

Adderall XR improves symptoms and quality of life of adult patients with ADHD

Nov. 4, 2005

Analgesic agents revealed in recent patents

Nov. 3, 2005

Antibody-derived GLYX-13 possesses cognitive-enhancing properties

Nov. 3, 2005

Protocol accepted for phase IIb MS trial of Tovaxin

Nov. 3, 2005

Enrollment discontinued in phase III study of Reopro for acute ischemic stroke

Nov. 3, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...